1. Barrow EW, Bourne PC, Barrow WW. Functional cloning of
Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim. Antimicrob Agents Chemother. 2004; 48:4643–4649.
Article
2. Berger T, Kassirer M, Aran AA. Injectional anthrax - new presentation of an old disease. Euro Surveill. 2014; 19:20877.
Article
3. Cavallo JD, Ramisse F, Giradet M, Vaissaire J, Mock M, Hernandez E. Antibiotic susceptibilities of 96 isolates of
Bacillus anthracis isolated in France between 1994 and 2000. Antimicrob Agents Chemother. 2002; 46:2307–2309.
Article
4. Clinical and Laboratory Standards Institute (CLSI). Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. CLSI Guideline M45. 3rd ed. Wayne: CLSI;2016.
5. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. 27th ed. Wayne: CLSI;2017.
6. Esel D, Doganay M, Sumerkan B. Antimicrobial susceptibilities of 40 isolates of
Bacillus anthracis isolated in Turkey. Int J Antimicrob Agents. 2003; 22:70–72.
Article
7. Fasanella A, Galante D, Garofolo G, Jones MH. Anthrax undervalued zoonosis. Vet Microbiol. 2010; 140:318–331.
Article
8. Fasanella A, Losito S, Trotta T, Adone R, Massa S, Ciuchini F, Chiocco D. Detection of anthrax vaccine virulence factors by polymerase chain reaction. Vaccine. 2001; 19:4214–4218.
Article
9. Fasanella A, Van Ert M, Altamura SA, Garofolo G, Buonavoglia C, Leori G, Huynh L, Zanecki S, Keim P. Molecular diversity of
Bacillus anthracis in Italy. J Clin Microbiol. 2005; 43:3398–3401.
Article
10. Hudson MJ, Beyer W, Böhm R, Fasanella A, Garofolo G, Golinski R, Goossens PL, Hahn U, Hallis B, King A, Mock M, Montecucco C, Ozin A, Tonello F, Kaufmann SH. Bacillus anthracis: balancing innocent research with dual-use potential. Int J Med Microbiol. 2008; 298:345–364.
11. Sarker SD, Nahar L, Kumarasamy Y. Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods. 2007; 42:321–324.
Article
12. Turnbull PC, Sirianni NM, LeBron CI, Samaan MN, Sutton FN, Reyes AE, Peruski LF Jr. MICs of selected antibiotics for
Bacillus anthracis,
Bacillus cereus,
Bacillus thuringiensis, and
Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest. J Clin Microbiol. 2004; 42:3626–3634.
Article
13. Van Ert MN, Easterday WR, Huynh LY, Okinaka RT, Hugh-Jones ME, Ravel J, Zanecki SR, Pearson T, Simonson TS, U'Ren JM, Kachur SM, Leadem-Dougherty RR, Rhoton SD, Zinser G, Farlow J, Coker PR, Smith KL, Wang B, Kenefic LJ, Fraser-Liggett CM, Wagner DM, Keim P. Global genetic population structure of Bacillus anthracis. PLoS One. 2007; 2:e461.